Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000083.xml
Synlett 2013; 24(17): 2305-2309
DOI: 10.1055/s-0033-1338975
DOI: 10.1055/s-0033-1338975
letter
Ascorbic Acid Based Ionic Liquids: Recyclable and Efficient Catalytic Systems for the Huisgen Cycloaddition
Further Information
Publication History
Received: 07 August 2013
Accepted after revision: 02 September 2013
Publication Date:
27 September 2013 (online)
Abstract
A new method for the Huisgen cycloaddition using an ascorbic acid based ionic liquid and a copper catalyst in an ionic liquid, under microwave irradiation, is described. The reaction times are short and a simple procedure for separation of the products is established. Good conversions are obtained and the ionic liquid based catalytic system can be recycled.
-
References and Notes
- 1a Wasserscheid P, Welton T. Ionic Liquids in Synthesis . Wiley-VCH; Weinheim: 2007
- 1b Welton T. Chem. Rev. 1999; 99: 2071
- 1c Hallett P, Welton T. Chem. Rev. 2011; 111: 3508
- 1d Wasserscheid P, Wilhelm K. Angew. Chem. Int. Ed. 2000; 39: 3772
- 2a Marra A, Chiappe Mele A. Chimia 2011; 65: 76
- 2b Xue H, Shreeve J. Eur. J. Inorg. Chem. 2005; 13: 2573
- 3 Cao H, McNamess L, Alper H. J. Org. Chem. 2008; 73: 3530
- 4a Sakaebe H, Matsumoto H. Electrochem. Commun. 2003; 5: 594
- 4b Matsumoto H, Yanagida M, Tanimoto K, Nomura M, Kitagawa Y, Miyazaki Y. Chem. Lett. 2000; 8: 922
- 5a Genin MJ, Allwine DA, Anderson DJ, Barbachyn MR, Emmert DE, Garmon SA, Graber DR, Grega KC, Hester JB, Hutchinson DK, Morris J, Reischer RJ, Ford CW, Zurenko GE, Hamel JC, Schaadt RD, Stapert D, Yagi BH. J. Med. Chem. 2000; 43: 953
- 5b Holla BS, Mahalinga M, Karthikeyan MS, Poojary B, Akberali PM, Kumari NS. Eur. J. Med. Chem. 2005; 40: 1173
- 6a Buckle DR, Rockell CJ. M, Smith H, Spicer BA. J. Med. Chem. 1986; 29: 2262
- 6b Buckel DR, Outred DJ, Rockell CJ. M, Smith H, Spicer BA. J. Med. Chem. 1983; 26: 251
- 6c Buckel DR, Rockell CJ. M, Smith H, Spicer BA. J. Med. Chem. 1984; 27: 223
- 7 Alvarez R, Velazquez S, San-Felix A, Aquaro S, De Clercq E, Perno C.-F, Karlsson A, Balzarini J, Camarasa MJ. J. Med. Chem. 1994; 37: 4194
- 8 Al-Masoudim NA, Al-Soud YA. Tetrahedron Lett. 2002; 43: 4021
- 9a Wu P, Feldman AK, Nugent AK, Hawker CJ, Scheel A, Voit B, Pyun J, Fréchet JM. J, Sharpless KB, Fokin VV. Angew. Chem. Int. Ed. 2004; 43: 3928
- 9b Aucagne V, Hänni KD, Leigh DA, Lusby PJ, Walker DB. J. Am. Chem. Soc. 2006; 128: 2186
- 9c Ye CF, Gard GL, Winter RW, Syvret RG, Twamley B, Shreeve JM. Org. Lett. 2007; 9: 3841
- 9d Liu QC, Zhao P, Chen YM. J. Polym. Sci. 2007; 45: 3330
- 9e Nandivada H, Jiang XW, Lahann J. Adv. Mater. 2007; 19: 2197
- 9f Angelos S, Yang YW, Patel K, Stoddart JF, Zink JI. Angew. Chem. Int. Ed. 2008; 45: 1435
- 10a Wacharasindhu S, Bardhan S, Wan Z.-K, Tabei K, Mansour TS. J. Am. Chem. Soc. 2009; 131: 4174
- 10b Liu Y, Yan W, Chen Y, Petersen JL, Shi X. Org. Lett. 2008; 10: 5385
- 10c Katritzky AR, Bobrov S, Kirichenko K, Ji Y, Steel PJ. J. Org. Chem. 2003; 68: 5713
- 10d Reid AK, McHugh CJ, Richie G, Graham D. Tetrahedron Lett. 2006; 47: 4201
- 10e Verma AK, Singh J, Chaudhary R. Tetrahedron Lett. 2007; 48: 7199
- 10f Dai Q, Gao W, Liu D, Kapzes LM, Zhang X. J. Org. Chem. 2006; 71: 3928
- 11a Rostovtsev VV, Green LG, Fokin VV, Sharpless KB. Angew. Chem. Int. Ed. 2002; 41: 2596
- 11b Tornoe CW, Christensen C, Meldal M. J. Org. Chem. 2002; 67: 3057
- 11c Chan TR, Hilgraf R, Sharpless KB, Fokin VV. Org. Lett. 2004; 6: 2853
- 11d Rodionov VO, Presolski SI, Diaz Diaz D, Fokin VV, Finn MG. J. Am. Chem. Soc. 2007; 129: 12705
- 12 Dinda E, Si S, Kotal A, Mandal T. Chem. Eur. J. 2008; 14: 5528
- 13 Zhijun D, Jiangna G, Lihua Q, Yinxia Z, Lin X, Feng Y. Polym. Chem. 2012; 3: 2439
- 14 All reagents and chemicals (reagent grade) were obtained from commercial suppliers, and were used as received. TLC was performed using Merck silica gel 60 F254 aluminum sheets. Column chromatography was performed using Kanto Chemical silica gel 60. Melting points were determined using a Yamoto MP-21 melting point apparatus. 1H (500 MHz) and 13C (125 MHz) NMR spectra were recorded in CDCl3 on a Bruker Avance DRX 500 spectrometer. Chemical shifts (δ) are expressed in ppm and are referenced to the residual peak of the solvent or TMS as an internal standard; coupling constants (J) are quoted in Hz. Mass analyses were performed using a JEOL AccuTOF LC-plus JMS-T100LP spectrometer. MALDI-MS (TOF) spectra were recorded on a Voyager DE-STR instrument; α-cyano-4-hydroxycinnamic acid was used as the matrix. Microwave irradiation was performed using a Shikoku Instrumentation CO., Inc. μReacter EX.
- 15 1-Ethyl-3-methyl-1H-imidazol-3-ium hydrogencarbonate (1a) Yield: 825 mg (4.79 mmol, 96%); yellow liquid. 1H NMR (500 MHz, CDCl3): δ = 1.38 (t, J = 7.5 Hz, 3 H), 2.50 (s, 3 H), 4.19 (q, J = 7.5 Hz, 2 H), 7.70 (s, 1 H), 7.79 (s, 1 H), 9.13 (s, 1 H). 13C NMR (125 MHz, CDCl3): δ = 15.6, 36.2, 44.6, 122.3, 123.9, 136.6. MALDI-MS (TOF): m/z [M]+ calcd for C6H11N2: 111.0; found: 111.0. 1-Butyl-3-methyl-1H-imidazol-3-ium hydrogencarbonate (1b) Yield: 971 mg (4.85 mmol, 97%); yellow liquid. 1H NMR (500 MHz, CDCl3): δ = 0.89 (t, J = 7.5 Hz, 3 H), 1.24 (m, 2 H), 1.75 (m, 2 H), 2.51 (s, 3 H), 4.16 (t, J = 7.5 Hz, 2 H), 7.70 (s, 1 H), 7.77 (s, 1 H), 9.13 (s, 1 H). 13C NMR (125 MHz, CDCl3): δ = 13.7, 19.2, 31.9, 36.3, 48.8, 122.7, 123.9, 136.9. HRMS (APCI): m/z [M + H]+ calcd for C8H15N2: 139.1235; found: 139.1241.
- 16 Ascorbic Acid Based Ionic Liquids 2a,b; General Procedure A solution of 1,3-disubstituted imidazolium hydrogencarbonate 1a,b (20 mmol) in MeOH (8 mL) was added to l-ascorbic acid (20 mmol). The resulting mixture was stirred at r.t. for 24 h and then evaporated. 3-Ethyl-1-methyl-1H-imidazol-3-ium ascorbate (2a) Yield: 5060.0 mg (17.2 mmol, 88%); orange liquid. 1H NMR (500 MHz, CDCl3): δ = 0.42–1.39 (m, 3 H), 2.50 (s, 3 H), 3.47–3.48 (m, 3 H), 3.48–3.80 (m, 1 H), 4.18–4.21 (m, 2 H), 7.70 (s, 1 H), 7.79 (s, 1 H), 9.17 (s, 1 H). 13C NMR (125 MHz, CDCl3): δ = 15.6, 36.1, 44.6, 63.5, 77.1, 115.9, 122.4, 123.9, 136.8, 167.5, 172.8, 176.2. MALDI-MS (TOF): m/z [M]+ calcd for C6H11N2: 111.0; found: 110.9. 3-Butyl-1-methyl-1H-imidazol-3-ium ascorbate (2b) Yield: 6179.2 mg (19.2 mmol, 98%); orange liquid. 1H NMR (500 MHz, CDCl3): δ = 0.95–0.98 (m, 3 H), 1.34–1.41 (m, 2 H), 1.84–1.90 (m, 2 H), 3.16–3.20 (m, 3 H), 3.76 (s, 3 H), 3.80–3.85 (m, 1 H), 4.15–4.17 (m, 2 H), 7.25 (s, 1 H), 7.27 (s, 1 H), 10.64 (s, 1 H). 13C NMR (125 MHz, CDCl3): δ = 13.7, 19.2, 31.8, 36.1, 48.9, 63.7, 76.9, 115.8, 122.7, 124.0, 137.2, 163.2, 167.6, 176.5. HRMS (ACPI): m/z [M]+ calcd for C8H15N2: 139.1235; found: 139.1253.
- 17 1,4-Disubstituted 1,2,3-Triazoles 3a–h; General Procedure A solution of azide (2.0 mmol), acetylene (3.0 mmol), CuSO4 (0.3 mmol) and 3-butyl-1-methyl-1H-imidazol-3-ium ascorbate (2b) (0.5 mmol) in [bmim]BF4 (2 mL) and H2O (1 mL) was stirred for 1 min at 80 °C under microwave irradiation. After the reaction was complete, the mixture was extracted with Et2O and the organic phase evaporated. The product was isolated by silica gel column chromatography. 1-Benzyl-4-phenyl-1H-1,2,3-triazole (3a) Yield: 451 mg (1.90 mmol, 96%); white solid; mp 122–124 °C. 1H NMR (500 MHz, CDCl3): δ = 5.59 (s, 2 H), 7.26–7.42 (m, 8 H), 7.66 (s, 1 H), 7.80 (m, 2 H). 13C NMR (125 MHz, CDCl3): δ = 54.3, 119.5, 125.7 (2 C), 128.1 (2 C), 128.2, 128.6, 128.8 (2 C), 129.2 (2 C), 130.6, 134.7, 148.3. HRMS (APCI): m/z [M + H]+ calcd for C15H14N3: 236.11877; found: 236.11002. 1-(4-Methylbenzyl)-4-phenyl-1H-1,2,3-triazole (3b) Yield: 481 mg (1.93 mmol, 97%); white solid; mp 108–111 °C. 1H NMR (500 MHz, CDCl3): δ = 2.36 (s, 3 H), 5.54 (s, 2 H), 7.19–7.23 (m, 4 H), 7.30–7.32 (m, 1 H), 7.39–7.41 (m, 2 H), 7.63 (s, 1 H), 7.78–7.80 (m, 2 H). 13C NMR (125 MHz, CDCl3): δ = 21.2, 54.0, 119.4, 125.7, 128.1 (2 C), 128.8 (2 C), 129.8 (2 C), 130.6 (2 C), 131.7 (2 C), 138.7, 148.2. HRMS (APCI): m/z [M + H]+ calcd for C16H16N3: 250.13442; found: 250.12573. 1-(4-Methoxybenzyl)-4-phenyl-1H-1,2,3-triazole (3c) Yield: 464 mg (1.75 mmol, 87%); white solid; mp 135 °C. 1H NMR (500 MHz, CDCl3): δ = 3.82 (s, 3 H), 5.52 (s, 2 H), 6.92 (d, J = 9 Hz, 2 H), 7.28–7.33 (m, 2 H), 7.38–7.40 (m, 3 H), 7.62 (s, 1 H), 7.79 (d, J = 9 Hz, 2 H). 13C NMR (125 MHz, CDCl3): δ = 53.8, 55.4, 114.2, 114.5 (2 C), 119.3, 120.0, 125.7, 126.7, 128.1, 128.8, 129.7 (2 C), 130.6 (2 C), 159.9. HRMS (APCI): m/z [M + H]+ calcd for C16H16N3O: 266.12934; found: 266.12823. 4-Phenyl-1-(3-phenylpropyl)-1H-1,2,3-triazole (3d) Yield: 420 mg (1.59 mmol, 80%); white solid; mp 82–83 °C. 1H NMR (500 MHz, CDCl3): δ = 2.31 (q, J = 7.5 Hz, 2 H), 2.70 (t, J = 7.5 Hz, 2 H), 4.41 (t, J = 7.5 Hz, 2 H), 7.19–7.35 (m, 6 H), 7.41–7.46 (m, 2 H), 7.72 (s, 1 H), 7.80–7.83 (m, 2 H). 13C NMR (125 MHz, CDCl3): δ = 30.4, 32.5, 50.6, 119.5, 125.7, 126.4, 126.1, 126.5, 128.49 (2 C), 128.5, 128.6, 128.7, 128.9, 130.7, 140.2, 147.8. HRMS (APCI): m/z [M + H]+ calcd for C17H18N3: 264.15007; found: 264.14639. 1-Benzyl-4-cyclopropyl-1H-1,2,3-triazole (3e) Yield: 353 mg (1.77 mmol, 89%); white solid; mp 58–59 °C. 1H NMR (500 MHz, CDCl3): δ = 0.80–0.83 (m, 2 H), 0.90–0.94 (m, 2 H), 1.89–1.94 (m, 1 H), 5.47 (s, 2 H), 7.13 (s, 1 H), 7.24–7.26 (m, 2 H), 7.33–7.38 (m, 3 H). 13C NMR (125 MHz, CDCl3): δ = 6.7, 7.7, 54.0, 119.6, 128.0, 128.2 (2 C), 128.6 (2 C), 129.0, 135.0, 150.7. HRMS (APCI): m/z [M + H]+ calcd for C12H14N3: 200.11877; found: 200.11366. 1-Benzyl-4-[4-(tert-butyl)phenyl]-1H-1,2,3-triazole (3f) Yield: 638 mg (2.19 mmol, quant.); white solid; mp 112–114 °C. 1H NMR (500 MHz, CDCl3): δ = 1.33 (s, 9 H), 5.58 (s, 2 H), 7.27–7.42 (m, 7 H), 7.63 (s, 1 H), 7.70–7.75 (m, 2 H). 13C NMR (125 MHz, CDCl3): δ = 31.3, 34.7, 54.2, 119.3, 125.3, 125.4, 125.7, 127.7, 128.0, 128.7 (2 C), 129.1, 131.9, 132.2, 134.8, 148.2, 151.3. HRMS (APCI): m/z [M + H]+ calcd for C19H22N3: 292.18137; found: 292.17627. 1-Benzyl-4-(3-phenylpropyl)-1H-1,2,3-triazole (3g) Yield: 550 mg (1.99 mmol, 99%); white solid; mp 64–65 °C. 1H NMR (500 MHz, CDCl3): δ = 1.95–2.01 (m, 2 H), 2.66 (t, J = 7.75 Hz, 2 H), 2.72 (t, J = 7.75 Hz, 2 H), 5.49 (s, 2 H), 7.15–7.18 (m, 5 H), 7.24–7.27 (m, 2 H), 7.33–7.39 (m, 4 H). 13C NMR (125 MHz, CDCl3): δ = 25.3, 31.1, 35.4, 54.0, 120.8, 125.8, 125.9, 127.9, 128.35, 128.39, 128.4 (2 C), 128.5, 128.6, 129.1, 135.0, 141.9, 148.4. HRMS (APCI): m/z [M + H]+ calcd for C18H20N3: 278.16572; found: 278.16215. 1-Benzyl-4-butyl-1H-1,2,3-triazole (3h) Yield: 319 mg (1.48 mmol, 74%); white solid; mp 60–62 °C. 1H NMR (500 MHz, CDCl3): δ = 0.91 (t, J = 7.25 Hz, 3 H), 1.33–1.40 (m, 2 H), 1.59–1.70 (m, 2 H), 2.69 (t, J = 7.75, 2 H), 5.49 (s, 2 H), 7.17 (s, 1 H), 7.24–7.26 (m, 2 H), 7.33–7.39 (m, 3 H). 13C NMR (125 MHz, CDCl3): δ = 13.8, 22.3, 25.4, 31.5, 53.9, 127.9, 128.2, 128.3, 128.6 (2 C), 128.8, 129.0, 135.1. HRMS (APCI): m/z [M + H]+ calcd for C13H18N3: 216.15007; found: 216.14352.